253 related articles for article (PubMed ID: 15205333)
1. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.
Bian D; Su S; Mahanivong C; Cheng RK; Han Q; Pan ZK; Sun P; Huang S
Cancer Res; 2004 Jun; 64(12):4209-17. PubMed ID: 15205333
[TBL] [Abstract][Full Text] [Related]
2. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
Sawada K; Morishige Ki; Tahara M; Ikebuchi Y; Kawagishi R; Tasaka K; Murata Y
Gynecol Oncol; 2002 Dec; 87(3):252-9. PubMed ID: 12468322
[TBL] [Abstract][Full Text] [Related]
4. Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
Li H; Ye X; Mahanivong C; Bian D; Chun J; Huang S
J Biol Chem; 2005 Mar; 280(11):10564-71. PubMed ID: 15653692
[TBL] [Abstract][Full Text] [Related]
5. Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells.
Jung ID; Lee J; Lee KB; Park CG; Kim YK; Seo DW; Park D; Lee HW; Han JW; Lee HY
Eur J Biochem; 2004 Apr; 271(8):1557-65. PubMed ID: 15066181
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
Symowicz J; Adley BP; Woo MM; Auersperg N; Hudson LG; Stack MS
Cancer Res; 2005 Mar; 65(6):2234-42. PubMed ID: 15781636
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
Mahanivong C; Chen HM; Yee SW; Pan ZK; Dong Z; Huang S
Oncogene; 2008 Feb; 27(9):1273-80. PubMed ID: 17724468
[TBL] [Abstract][Full Text] [Related]
8. Regulation of lysophosphatidic acid-stimulated tyrosine phosphorylation of mitogen-activated protein kinase by protein kinase C- and pertussis toxin-dependent pathways in the endothelial cell line EAhy 926.
McLees A; Graham A; Malarkey K; Gould GW; Plevin R
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):743-8. PubMed ID: 7741705
[TBL] [Abstract][Full Text] [Related]
9. Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho.
Sawada K; Morishige K; Tahara M; Kawagishi R; Ikebuchi Y; Tasaka K; Murata Y
Cancer Res; 2002 Nov; 62(21):6015-20. PubMed ID: 12414621
[TBL] [Abstract][Full Text] [Related]
10. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
Hurst JH; Henkel PA; Brown AL; Hooks SB
Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.
Hao F; Tan M; Xu X; Han J; Miller DD; Tigyi G; Cui MZ
Biochim Biophys Acta; 2007 Jul; 1771(7):883-92. PubMed ID: 17531530
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.
Ren J; Xiao YJ; Singh LS; Zhao X; Zhao Z; Feng L; Rose TM; Prestwich GD; Xu Y
Cancer Res; 2006 Mar; 66(6):3006-14. PubMed ID: 16540649
[TBL] [Abstract][Full Text] [Related]
14. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
Xu J; Lai YJ; Lin WC; Lin FT
J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
[TBL] [Abstract][Full Text] [Related]
15. RAFTK/Pyk2 mediates LPA-induced PC12 cell migration.
Park SY; Schinkmann KA; Avraham S
Cell Signal; 2006 Jul; 18(7):1063-71. PubMed ID: 16199135
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid signals through mitogen-activated protein kinase-extracellular signal regulated kinase in ovarian theca cells expressing the LPA1/edg2-receptor: involvement of a nonclassical pathway?
Budnik LT; Brunswig-Spickenheier B; Mukhopadhyay AK
Mol Endocrinol; 2003 Aug; 17(8):1593-606. PubMed ID: 12730329
[TBL] [Abstract][Full Text] [Related]
17. The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.
Ha JH; Ward JD; Varadarajalu L; Kim SG; Dhanasekaran DN
Cell Signal; 2014 Jan; 26(1):122-32. PubMed ID: 24055910
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY
Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446
[TBL] [Abstract][Full Text] [Related]
19. RNA interference reveals a differential role of FAK and Pyk2 in cell migration, leading edge formation and increase in focal adhesions induced by LPA in intestinal epithelial cells.
Jiang X; Jacamo R; Zhukova E; Sinnett-Smith J; Rozengurt E
J Cell Physiol; 2006 Jun; 207(3):816-28. PubMed ID: 16508947
[TBL] [Abstract][Full Text] [Related]
20. LPA-mediated migration of ovarian cancer cells involves translocalization of Gαi2 to invadopodia and association with Src and β-pix.
Ward JD; Ha JH; Jayaraman M; Dhanasekaran DN
Cancer Lett; 2015 Jan; 356(2 Pt B):382-91. PubMed ID: 25451317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
